Clinical Updates
FDA Bans Generic Version of Oxycontin
On the day when the patent for the original version of OxyContin was set to…
Generic Zovirax® Launches
On Wednesday, April 3, generic Zovirax® ointment launched. Annual US brand sales of the 30gm…
Generic Luvox® CR Launches
On March 13, Par Pharmaceuticals received final FDA approval and launched the generic equivalent of…
Changes to the Controlled Substance Schedules – New York
Changes to the Controlled Substance Schedules in Section 3306 of the New York State Public…
Generic Zometa® Launches
Generic Zometa® Launches – On March 5, 2013, Sagent Pharmaceuticals received final FDA approval and…
Generic Suboxone® Launches
On March 5, 2013, Amneal Pharmaceuticals LLC announced that its generic equivalent of Suboxone®, Buprenorphine…
Generic Antara® Launches
On Friday, February 22, Mylan received final FDA approval and launched the generic equivalent of…
Generic Sulfamylon® Launches
On February 2, 2013, Par Pharmaceutical received final FDA approval for and commenced shipping the…
Illinois – Final Physician-Dispensed Pharmacy Rule Published
The IWCC’s final repackaged drug repricing methodology was published in the December 7 edition of…
Generic Olux E Foam® Launches
On February 1, 2013, Perrigo received final FDA approval for and commenced shipping the generic…
